Morgan Stanley Healthcare
Does anyone have any insight on this group?
JPM is the undisputed leader in healthcare banking. Goldman isn't that strong in the space, from what I understand, nor are many of the other BB's. And then you have middle market firms like Jefferies, Cowen, Leerink that have good deal flow but don't have the BB brand name pulling for them.
Where does Morgan Stanley fit in - can anyone familiar with the group offer some insight? Thanks.
Bump
They were the sole advisor to Cigna in the Cigna-Express Scripts deal, so I think it's reasonable to conclude their healthcare team is pretty decent...
Lazard and Centerview were both on the Cigna/Express Scripts as well as the CVS/Aetna deal.
https://www.thomsonreuters.co.jp/content/dam/openweb/documents/pdf/japa…</a">https://www.thomsonreuters.co.jp/content/dam/openweb/documents/pdf/japa…
Healthcare in the US 2017
1- GS ($126bn)
2- Barclays ($95bn)
3- Lazard ($85bn)
I don't know how students come here and say stuff like this without any regard for actual data. Who told you JPM was an "undisputed leader"? There are no undisputed leaders in IBD it's a very competitive market even holy GS only has 20% of market share in M&A. You should be more careful re soundbites
THANK YOU +++
JPM is definetely #1 in healthcare.....
Above ranking being based on deal size skews it. You can be a print advisor on a Pfizer deal and be sitting at $100bn+ league table cred.
Total fee (including Lev Fin and Equity) would put JPM on top. But they have lost some footing over last couple of years compared to say 2014. GS probably equally strong in M&A and equity. GS does very well with public company sell sides. Among BBs BAML and Barclays come next. MS does some big deals but is smaller / less volume. CS lost most of their guys but still shows up now and then. UBS rarely but sometimes. DB/(RBC/WF) non factors.
Among boutiques Lazard and Centerview gets most. Centerview got some GS/CS people recently and also have ex-ML people. Evercore, Guggenheim probably after that. You’ll find all these guys do deals based on their sub vertical focus / power MDs.
And if you want to pump out sponsor sell sides CIMs, can’t go wrong with Jefferies and Moelis. Would argue Jefferies does more deal than any of the above even. Harris Williams, William Blair, Houlihan Lokey does lot for the smaller sponsor sell sides.
Guggenheim was lead M&A counsel for the failed Allergan acquisition deal. Does that count for anything?
Et aliquam quo praesentium ratione quia ut. Illo ab voluptatem autem autem omnis mollitia. Reiciendis et impedit eos. Sit dolore temporibus impedit ratione. Ex ex dignissimos ab velit fuga aliquid.
At dolore possimus qui omnis. Ratione deleniti necessitatibus quia. Debitis totam eos vel distinctio.
Veritatis maxime et voluptas harum quos. Laboriosam iusto reprehenderit unde incidunt. Esse quia vero voluptatem veritatis rerum voluptates et. Est qui qui omnis saepe quia iste velit. Dolores modi accusamus maxime est. Aut qui est eum neque quos ut iste.
Quia sunt tempore iure aliquam veritatis. Voluptatem non nisi omnis nemo accusamus. Non doloribus tenetur assumenda et est. Et qui officia praesentium voluptatem quidem sit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...